October 2013

A study examines the potential for an increased risk of coronary heart disease because of skipping breakfast.

Rethinking medical education about obesity and more news that your patients are reading.

A review of the ACCOAST, ASSURE, Edoxaban Hokusai-VTE, EXAMINE, PRAMI, RE-ALIGN, and SAVOR-TIMI 53, and TAO studies presented at the European Society of Cardiology 2013 Congress.

Aparna M. Bhagavat, MD, FACC, says gliptins have a promising role in the control of type 2 diabetes, as they decrease A1C without hypoglycemia, weight gain, or any obvious adverse effects on cardiovascular outcomes.

In pulmonary arterial hypertension patients, riociguat serves as a reasonable first-line alternative to PDE-5 inhibitors or in combination therapy with an endothelin antagonist or inhaled prostacyclin analogues.

Examining data from the National Health and Nutrition Exam Survey tells physicians a great deal about childhood obesity and risk factors for high blood pressure.

Diana Fancher, DNP, MBA, RN, says replacing the fee-for-service model with bundled payments has its own set of problems.

The wide variation in geographic utilization of coronary angiography, percutaneous coronary intervention (PCI), and coronary artery bypass graft (CABG) surgery, despite reimbursement structure, suggests that capitation alone may not lead to reductions in variation.

Rabab Mohsin, MD, reviews adverse outcomes among women from the Women's Ischemia Syndrome Evaluation (WISE) study.

Have the Appropriate Use Criteria for transthoracic echocardiography achieved their goal of having a significant clinical impact on physician decision making?